Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT 752.70
-5.20 (-0.69%)
At close: Apr 28, 2026
Ambee Pharmaceuticals Revenue
Ambee Pharmaceuticals had revenue of 42.23M BDT in the quarter ending December 31, 2025, a decrease of -19.65%. This brings the company's revenue in the last twelve months to 183.57M, down -18.88% year-over-year. In the fiscal year ending June 30, 2025, Ambee Pharmaceuticals had annual revenue of 230.55M with 5.13% growth.
Revenue (ttm)
183.57M
Revenue Growth
-18.88%
P/S Ratio
9.84
Revenue / Employee
387.28K
Employees
474
Market Cap
1.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 230.55M | 11.25M | 5.13% |
| Jun 30, 2024 | 219.30M | 21.21M | 10.71% |
| Jun 30, 2023 | 198.10M | 17.10M | 9.45% |
| Jun 30, 2022 | 180.99M | 82.02M | 82.86% |
| Jun 30, 2021 | 98.98M | -186.33M | -65.31% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma Aids | 474.48M |
| Indo-Bangla Pharmaceuticals | 221.18M |
| Silco Pharmaceuticals | 431.04M |
| Silva Pharmaceuticals | 356.99M |
| Libra Infusions | 197.03M |
| Advent Pharma | 516.48M |
| Central Pharmaceuticals | 34.45M |
| Techno Drugs | 3.15B |